Angiotensin converting enzyme (ACE) activity levels in insulin-independent diabetes mellitus and effect of ACE levels on diabetic patients with nephropathy

被引:0
|
作者
Üstündag, B
Canatan, H
Cinkilinc, N
Halifeoglu, I
Bahcecioglu, IH
机构
[1] Firat Univ, Coll Med, Dept Biochem & Clin Biochem, TR-23119 Elazig, Turkey
[2] Firat Univ, Coll Med, Dept Internal Med, TR-23119 Elazig, Turkey
关键词
angiotensin converting enzyme (ACE); diabetes mellitus (DM); nephropathy;
D O I
10.1002/(SICI)1099-0844(200001/03)18:1<23::AID-CBF843>3.0.CO;2-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Involvement of complications is considered to be one of the major factors in the prognosis of diabetes mellitus (DM). Recent studies indicate that most diabetic complications such as nephropathy and hypertension are vascular-originated, Renin-angiotensin involvement, especially changes in ACE activity level, is considered to be a key factor since ACE converts angiotensin I to angiotensin II which is a potent vasoconstrictor and plays a vital role in the regulation of blood pressure. Our present study focused on ACE activity levels along with blood glucose and HbA(1c) levels in diabetic patients with (n = 18) or without (ii = 25) nephropathy as compared to control subjects (n = 25), Blood glucose levels were significantly higher in both diabetic groups compared to controls (p < 0.001). On the other hand. compared to controls, blood HbA(1c) levels were slightly higher in DM patients without complications whereas they were significantly increased in nephropatic DM patients (p < 0.001). There was a very strong increase (p < 0.001) at the level of ACE activity in both of the diabetic groups (with nephropathy: 47.11 +/- 3.70 U l(-1); without complications: 43.72 +/- 2.93 U l(-1): controls: 25.15 +/- 2.30 U l(-1)). ACE activity levels were also significantly higher in diabetic patients with nephropathy than in type II DM patients without complication (p < 0.01). Our results demonstrate that ACE activity levels are increased in diabetic patients. Additional significant increase in ACE activity levels in diabetic patients with complications such as nephropathy supports the hypothesis that ACE activity has an essential role in the development of complications in diabetes, Copyright (C) 2000 John Wiley &: Sons, Ltd.
引用
收藏
页码:23 / 28
页数:6
相关论文
共 50 条
  • [1] Angiotensin Converting Enzyme (Ace) Inhibitors in the Treatment of Diabetic Nephropathy
    Kumari, Sunita
    Kumar, S. L. Hari
    Navis, Silvia
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND PHYTOPHARMACOLOGICAL RESEARCH, 2015, 4 (04): : 211 - 217
  • [2] Polymorphism of the angiotensin converting enzyme (ACE) gene in patients with diabetic nephropathy.
    SemetkowskaJurkiewicz, E
    Nowakowski, M
    Bigda, J
    Pawlowski, R
    Narkiewicz, K
    Bieniaszewski, L
    Chrostowska, M
    KrupaWojciechowska, B
    DIABETOLOGIA, 1997, 40 : 2049 - 2049
  • [3] Role of angiotensin-converting enzyme (ACE) gene polymorphism and antiproteinuric effect of ACE inhibition in diabetic nephropathy
    Rossing, K
    Jacobsen, P
    Tarnow, L
    Rossing, P
    Parving, HH
    DIABETOLOGIA, 1996, 39 : 1132 - 1132
  • [4] Association of Angiotensin converting Enzyme (ACE) gene polymorphism and diabetic nephropathy
    Golmohamadi, T.
    Nikzamir, A.
    Nakhjavani, M.
    Zahrai, M.
    Amirzargar, A.
    Saffari, R.
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2006, 35 (03): : 14 - 21
  • [5] Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy
    Jacobsen, P
    Rossing, K
    Rossing, P
    Tarnow, L
    Mallet, C
    Poirier, O
    Cambien, F
    Parving, HH
    KIDNEY INTERNATIONAL, 1998, 53 (04) : 1002 - 1006
  • [6] Angiotensin-Converting Enzyme (ACE) activity and genotype predict low blood glucose levels in Type 2 Diabetes Mellitus
    Ko, M. S. M.
    Lee, W. K.
    Ang, L. C.
    Bee, Y. M.
    Goh, S. Y.
    Teh, M. M.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 197
  • [7] Role of angiotensin-converting enzyme (ACE) gene polymorphism and antiproteinuric effect of ACE inhibition in diabetic nephropathy.
    Rossing, K
    Jacobsen, P
    Tarnow, L
    Rossing, P
    Cambien, F
    Parving, HH
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A0593 - A0593
  • [8] Lower circulating levels of angiotensin-converting enzyme (ACE) in patients with schizophrenia
    Mohite, Satyajit
    de Campos-Carli, Salvina M.
    Rocha, Natalia P.
    Sharma, Shiva
    Miranda, Aline S.
    Barbosa, Izabela G.
    Salgado, Joao, V
    Simoes-e-Silva, Ana Cristina
    Teixeira, Antonio L.
    SCHIZOPHRENIA RESEARCH, 2018, 202 : 50 - 54
  • [9] SERUM ANGIOTENSIN CONVERTING ENZYME ACE LEVELS IN PATIENTS AFTER LUNG SURGERY
    SZECHINSKI, J
    KOLODZIEJ, J
    SKOCZYNSKA, A
    SMOLIK, K
    FASEB JOURNAL, 1988, 2 (06): : A1607 - A1607
  • [10] Antiproteinuric effect of angiotensin I-converting enzyme inhibits (ACE) in the youth with diabetic nephropathy and ACE gen polymorphism
    Sivous, GI
    Kasatkina, EP
    Demurov, LM
    Voichik, EA
    Kondratiev, YY
    Chistyakov, DA
    Strokov, IA
    Nosikov, VV
    DIABETOLOGIA, 1998, 41 : A294 - A294